Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00618657
Title Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of California, Irvine

breast cancer


Carboplatin + Nab-paclitaxel + Trastuzumab

Bevacizumab + Carboplatin + Nab-paclitaxel

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
*Shaded cells indicate that there was no data available from for the field